5Takeda Y, Yoneda T, Demura M, et al. Calcineurin inhibition attenuates mineralocorticoid-induced cardiac hypertrophy [J ]. Circulation ,2002,105(6) :677 - 9.
6Muscholl MW, Schunkert H, Muders F, Elsner D, et al. Neuro-hormonal activity and left ventricular geometry in patients with essential arterial hypertension[J ]. Am Heart J, 1998,135( 1 ) : 58 - 66.
7Tsutamoto T, Wada A, Maeda K, et al. Effect of spironohctone on plasma brain natriuretic peptide and left ventricular remodeling in patients with congestive heart failure[J ]. J Am Coil Cardiol, 2001,37(5) : 1228 - 33.
8Pitt B, Zannad F, Remme WJ, et al. The effect of spironolaetone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators[J ]. N Engl J Med,1999,341(10) :709 - 17.
9TakedaY, Miyamori I, InabaS, et al. Vascular aldoaterone in gentically hypertensive rats[J ]. Hypertens, 1997,29:45 - 48.
10Weber KT, Sun Y,Guarda E. Structural remodeling in hypertensive heart disease and the role of hormones[J]. Hypertens, 1994,23 (part 2) :869 - 877.
